Brain Metastases In ErbB2-Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours
- Status
- TERMINATED
- Phase
- PHASE2
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma
- Status
- TERMINATED
- Phase
- NA
Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Standard Versus Continuous Capecitabine in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen
- Status
- COMPLETED
- Phase
- PHASE3
Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
- Status
- UNKNOWN
- Phase
- PHASE3